Pharmacokinetics of indinavir and low-dose ritonavir in children with HIV-1 infection.

Suppr

超能文献

作者信息

van Rossum A M, de Groot R, Hartwig N G, Weemaes C M, Head S, Burger D M

出版信息

AIDS. 2000 Sep 29;14(14):2209-10. doi: 10.1097/00002030-200009290-00022.

DOI:10.1097/00002030-200009290-00022

PMID:11061667

Abstract

摘要

相似文献

Pharmacokinetics of indinavir and low-dose ritonavir in children with HIV-1 infection.

AIDS. 2000 Sep 29;14(14):2209-10. doi: 10.1097/00002030-200009290-00022.

Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients.

Clin Infect Dis. 2004 Feb 1;38(3):426-9. doi: 10.1086/380794. Epub 2004 Jan 12.

Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adults.茚地那韦、洛匹那韦和利托那韦联合用药在多次接受治疗的HIV-1感染成人中的药代动力学及耐受性

Eur J Med Res. 2006 Jun 30;11(6):236-44.

Ritonavir/indinavir combination study shows promising dosing results.利托那韦/茚地那韦联合用药研究显示出有前景的给药结果。

AIDS Patient Care STDS. 1998 Feb;12(2):146-7.

Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients.茚地那韦单药及与利托那韦联用在HIV-1感染患者中的群体药代动力学。

Br J Clin Pharmacol. 2005 Sep;60(3):276-86. doi: 10.1111/j.1365-2125.2005.02436.x.

Optimizing indinavir regimens.优化茚地那韦治疗方案。

HIV Med. 2000 Jul;1 Suppl 2:7-11. doi: 10.1046/j.1468-1293.2000.00005.x.

Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients.在感染HIV-1的泰国患者中，每日两次服用低剂量茚地那韦/利托那韦400/100毫克的药代动力学研究。

Antivir Ther. 2005;10(2):301-7.

Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients.茚地那韦联合或不联合小剂量利托那韦在泰国HIV感染患者中的药代动力学和药效学研究

J Antimicrob Chemother. 2003 May;51(5):1231-8. doi: 10.1093/jac/dkg198. Epub 2003 Mar 28.

Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams every 8 hours in human immunodeficiency virus-infected patients.在人类免疫缺陷病毒感染患者中，与每8小时服用800毫克茚地那韦相比，每12小时分别服用667毫克茚地那韦和100毫克利托那韦的药代动力学。

Antimicrob Agents Chemother. 2004 Nov;48(11):4200-8. doi: 10.1128/AAC.48.11.4200-4208.2004.

Once-daily indinavir plus ritonavir: preliminary results of the PIPO study.每日一次茚地那韦联合利托那韦：PIPO研究的初步结果。

AIDS. 2000 Nov 10;14(16):2621-3. doi: 10.1097/00002030-200011100-00032.

引用本文的文献

Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.儿童和青少年抗逆转录病毒治疗的药代动力学优化。

Clin Pharmacokinet. 2011 Mar;50(3):143-89. doi: 10.2165/11539260-000000000-00000.

Indinavir/low-dose ritonavir containing HAART in HIV-1 infected children has potent antiretroviral activity, but is associated with side effects and frequent discontinuation of treatment.在感染HIV-1的儿童中，含茚地那韦/低剂量利托那韦的高效抗逆转录病毒疗法具有强大的抗逆转录病毒活性，但会引发副作用且治疗常被中断。

Infection. 2007 Jun;35(3):186-9. doi: 10.1007/s15010-007-6068-1.

Pharmacokinetics of antiretroviral therapy in HIV-1-infected children.抗逆转录病毒疗法在HIV-1感染儿童中的药代动力学

Clin Pharmacokinet. 2005;44(9):935-56. doi: 10.2165/00003088-200544090-00004.

Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected children.茚地那韦联合小剂量利托那韦在1型人类免疫缺陷病毒感染儿童中的药代动力学

Antimicrob Agents Chemother. 2004 May;48(5):1904-7. doi: 10.1128/AAC.48.5.1904-1907.2004.

Antiretroviral pharmacokinetics in the paediatric population: a review.儿科人群中的抗逆转录病毒药物动力学：综述

Clin Pharmacokinet. 2002;41(14):1115-33. doi: 10.2165/00003088-200241140-00001.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验